Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Adults With Very Unstable Type 1 Diabetes, is the DBLHU Closed-Loop Insulin Delivery System Able to Improve Blood Glycemic Control Compared to Low-Glucose-Predictive-Suspend System: Two-center, Randomized, Open-label Study

NCT04042207 is registered in ClinicalTrials.gov with Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète as lead sponsor.

NCT NCT04042207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04042207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Adults With Very Unstable Type 1 Diabetes, is the DBLHU Closed-Loop Insulin Delivery System Able to Improve Blood Glycemic Control Compared to Low-Glucose-Predictive-Suspend System: Two-center, Randomized, Open-label Study
Lead sponsor
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Phase
Not applicable
Overall status
Completed
Start date
September 3, 2019
Completion date
March 22, 2021
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

closed-loop, diabetes mellitus, brittle, diabetes mellitus, type 1